ALTERITY THERAPEUTICS LIMITED (ATHE) Financial Statements
ALTERITY THERAPEUTICS LIMITED (ATHE) files with the U.S. Securities and Exchange Commission under CIK 0001131343. 10KGenie shows its annual statements from SEC filings.
Key Figures, Fiscal Year 2026
- Net Income
- -23.40 million AUD
- Total Assets
- 46.02 million AUD
- Net Cash from Operations
- -22.52 million AUD
Fiscal year ended Jun 30, 2026. Latest periodic SEC filing: Aug 28, 2026. Source: SEC filings (EDGAR XBRL). Amounts in AUD.
Open the full financial statements for ATHE in 10KGenie
Data from SEC EDGAR filings. 10KGenie is not affiliated with the SEC. SEC Filing History